Sana Biotechnology Inc (NASDAQ:SANA) currently has a daily average trading volume of 7.30M but it saw 2982689 shares traded in last market. With a market cap of 569.34M USD, the company’s current market price of $2.55 remained unchanged while comparing to the previous closing price of $2.55. In past 52 weeks, the stock remained buoying in the range of price level as high as $10.50 and as low as $1.52.
Taking a look at 20-day trading activity of Sana Biotechnology Inc (SANA) gives us an average price of $2.80, while its current price level is -75.71% below from 52-week high level whereas it is 67.76% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $2.79 while that of 200 days or SMA-200 reads an average of $4.28. A closer look into the stock’s movement over the week reveals that its volatility is standing at 8.02% during that period while stretching the period over a month that increases to 8.45%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 42.16 which implies that the stock is in neutral territory.
Rodman & Renshaw issued its recommendations for the stock as it initiated the price target for the stock is $16.
Over the week, SANA’s stock price is moving -1.54% down while it is -19.56% when we observe its performance for the past one month. Year-to-date it is 56.44% up and over the past year, the stock is showing a downside performance of -73.04%.
The company is expected to be releasing its next quarterly report in April, for which analysts forecasted an EPS of -0.26 while estimate for next year EPS is -1.14.
Currently, Sana Biotechnology Inc’s total number of outstanding shares is 223.11M with 8.64% of that held by the insiders while 94.44% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -80.91% and return on equity (ROE) at -92.90%. Stock’s beta reads 1.63. Stock has a price to book (P/B) ratio of 1.95. Its return on asset (ROA) is -51.36% on average.
